Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Consortium to Develop Stem Cell Research Tools

NEW YORK (GenomeWeb News) – Invitrogen has signed a non-binding letter of intent to collaborate with the International Regulome Consortium on the development of stem cell research tools, the firms announced yesterday at the Biotechnology Industry Organization annual meeting in San Diego.
 
Under terms of the pact, Invitrogen will contribute unspecified services and technologies to help IRC researchers map the “genetic circuit board” that regulates how stem cells give rise to specialized cells, such as neurons.
 
The IRC was formed in 2004 with seed funding from the Government of Ontario, Canada. It currently includes 58 researchers at 34 institutions in 12 countries.
 
“Invitrogen brings tremendous expertise and strength in stem cell biology to this important international consortium,” said IRC Scientific Director Michael Rudnicki, who also is a senior scientist at the Ottawa Health Research Institute. “Without question, this participation will accelerate the IRC’s research program.”

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.